ARTICLE | Company News

Management tracks: Pfenex, Alvotech, uniQure

August 7, 2017 11:54 PM UTC

Biosimilars company Pfenex Inc. (NYSE-M:PFNX) named Evert Schimmelpennink CEO, president and secretary. He succeeds interim CEO Patrick Lucy, who will continue as CBO. Rasmus Rojkjaer was named CEO at biosimilar company Alvotech ehf (Reykjavik, Iceland), replacing Schimmelpennink who stepped down.

Gene therapy company uniQure N.V. (NASDAQ:QURE) announced several appointments including Scott McMillan as COO. He was SVP of quality and technical operations at AMAG Pharmaceuticals Inc. (NASDAQ:AMAG). The company named co-founder Sander van Deventer CSO. He is a managing partner at Forbion Capital Partners and a professor of translational gastroenterology at Leiden University Medical Center. In addition, the company promoted Christian Klemt to chief accounting officer from global controller...